Á lódáil...
Development of neuroleptic agents: pharmacogenetics and current safety issues of regulatory concern
The development of safe and effective new drug treatments for schizophrenia poses a challenging task. This class of drugs is known to be associated with a wide range of serious and troublesome safety problems that include neurological, cardiac, endocrine, and metabolic side effects. Many of these dr...
Na minha lista:
Príomhúdar: | |
---|---|
Formáid: | Artigo |
Teanga: | Inglês |
Foilsithe: |
Les Laboratoires Servier
2002
|
Ábhair: | |
Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3181691/ https://ncbi.nlm.nih.gov/pubmed/22033499 |
Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|